Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Turn Therapeutics Inc.NASDAQ: TTRX
Short-term Debt · Q1 FY2026 · quarter ended Mar 2026
Short-term debt of $47.8K in Q1 FY2026
Q1 FY2026 short-term debt was $47.8K.
Context
- Short-term debt amounted to 0.3% of total assets at the end of Q1 FY2026.
- Short-term debt increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Short-term Debt vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 short-term debt of $47.8K is the 4th highest of the 9 companies compared; the peer median is $0.
- Short-term debt amounts to 0.3% of total assets for TTRX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $140.65M | +19141.0% | +546.1% | 75.4% | |
| Mar 2026 | $206.85K | — | — | 0.7% | |
| Mar 2026 | $194K | +20.5% | -21.5% | 0.5% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $47.8K | — | — | 0.3% |
IRDOpus Genetics, Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding TTRX) | $0 | +20.5% | +262.3% | 0.0% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.